Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well if said company buys and is worth more Money….then your not being diluted down on.
It’s more like you have less shares of a more valuable company.
And the valuations are not the market pricing….as that’s just what traders are willing to buy and sell for. The valuation comes in the form of actual tangible and intangible assets.
Agreed. Bought my first shares here in 2018 before IMUC fell apart. Have averaged down and kept buying. I had almost 7% of float before merger.
Still waiting. Just want to see something big happen here.
I’m not a quick money trader, I suck at that.
I am however, an investor by trade.
The risk taken here with the common is worth the reward.
Yes sir. That’s over now. Thus the results need.
Where do you see them going from here?
I believe that 30 day period is required
Haha. Nope. But there was a 30 day quiet period after canceling the funding raise.
Trial seems positive.
Not sure where they go from here but they have to have some funding plan to further trials.
They should be wrapping up testing on toxicity of their EOM613.
“Results indicate that EOM613 treatment mitigates cytokine release in patients with COVID-19 pulmonary vascular inflammation.”
When they merged with a larger company I assume the intentions were to help move this along faster as getting into phase 3 is not an easy task. So they must be close to something….
could be wrong so do not go off my judgement on this particular company
BUT
It seems like it doesn’t belong on the OTC at all.
I’ll leave it at that.
Like your positivity.
Per Irach in an email last week
Thanks for reaching out.
As you are possibly aware, the SEC rules specifically require that when a S-1 registration statement is put out there and still effective, a public company must maintain a 'quiet period" wherein a company's management and marketing teams cannot release any additional information or offer opinions on the firm than those which are present and contained in the registration statement. That explains the long silence and lack of news flow.
Now that the S-1 has been duly withdrawn, one may expect such information and updates to be released when available, with the caveat that there is an additional 30-day moratorium period after the S-1 has been withdrawn. One may therefore expect a news flow post that 30-day moratorium period.
Regards,
Irach
Good for them.
Eventually this will be a big ordeal once they get everything in place.
Otherwise the Goldberg family will be out a lot of money. It makes more sense for this to take off anyways with a quite a few “possible” vaccinations going into phase 3 trail.
If that happens (it seems like two may get approved around same time….) this company will shoot up in value almost
10 fold.
But I’m never selling my shares.
Nobody needs to.
Any thoughts on them scrapping the up list and capital raising?
They have no say.
This I know for fact. If this were the case, then naked shorting would be the best and only play.
We all know that’s a mistake
Thanks for the tip Veteran. Haha. Anyways hope we make out like a bandit here one day. Patience I do have. Trust the process.
Mad?
Too old for that
Never show your hand on ihub (of all places…)
Rookie mistake number 1.
Haha. How many you got? I showed mine and called you out. Seem like it made you mad.
Call TD and speak with them. They are “on order” and cannot legally be shorted. We all know how well they follow that rule.
Also by keeping your shares that high in price….the lenders the can use them knowing it’s going to sit.
If you truly are an investor, this should be a walk in the park.
Only proof I need is the amount of complaining and inexperience I see.
Especially with the amount of money you claim. Your pic is meaningless also. I can also change HTML coding…it’s not hard if you grew up in my era of the late 80’s early 90’s
So based off everything you’ve posted,
You should either not be investing at all…
OR
You work for a lender/investor that either wants more shares or wants us to sell them.
Either way never going to happen and that’s why I’m here to make sure of it.
I am holding 126,125 shares.
See link for proof. https://www.dropbox.com/sh/09afv937onxmurw/AACgWWag5cTz_fEj5EtRu39ga?dl=0
Put your shares on there and I’ll take them all.
I have no problem waiting.
But honestly I don’t think you have the shares.
You’ve been trying to get us to sell for over a year now.
NEVER GOING TO HAPPEN.
Which lender are you working for?
Well not looking good. They cancelled their biggest trial. Back to waiting.
I agree this should rocket in price. Doesn’t look like they have raised the money yet. Perhaps a slow down with markets and banking fiasco.
S1 was amended and filed Dec 20 2022. https://www.otcmarkets.com/filing/html?id=16268613&guid=THA-kpnke4QtQth
Waiting for financials to drop and see what’s in them. They will have to have audited financials and be SEC reporting for the S1 to be live (or at least that’s my understanding).
Should happen sometime this year though.
I’ve called their number several times. About a month ago Irach Taraporewala actually answered. He didn’t have much to say but did confirm they were diligently working on data review to get news out.
No doubt they know how to raise funds and will time news with funding.
NO THEORY.
Major increase in price coming.
They raised capital without issue and have 2 vaccines/IP on the table for phase 3.
That’s more than enough for me.
This could go at anytime after the long low volume sell off. And I feel that it’s only like this now due to market conditions. They got money at the right time before the rates skyrocketed.
Anybody have any theories here? What’s really going on?
Would love to see $10.00!
Slow accumulation been happening the past few months. Looking for great things here!
ImmunoCellular Therapeutics Ltd. changed to EOM Pharmaceutical Holdings Inc.
https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
How long has VNDM been in the ask? They selling shares now?
The valuation is what will change.
And most biotechs have huge multipliers
Possibly. But its going to depend on where they price those reg A shares. I think we have more waiting to do. But I would say conservative estimate is where they price those shares.
$5.00 still too low.
Im looking for $5.00 here sooner than later.
$1 is much too low.
This stock could go very big.
Like gap fills at $10+….
Some think I’m crazy (I mean I could be…)
But honestly…I’d be surprised if this isnt trading over the $1 range when they move a few phase 2’s into 3.
Phase 3’s can monetize and reap royalties very quickly OR they end up selling the patents and IP for millions. Either way it seems to me like this is very undervalued
Nice buys today. Hoping to be over a buck soon
Raised $750k with convertible note. https://www.sec.gov/Archives/edgar/data/822411/000149315222025629/xslFormDX01/primary_doc.xml
We’re going to laugh all the way to the bank here!
Nice to see myself in the green here finally. Shares are wanted. Holding mine to see what happens here. $1 plus will come shortly
We shall discuss later when confirmed.
There can be only one
Something derogatory or Continuous Net Settlement.
The real question is….what do you think it means???
Educate me on the meaning of CNS and how it applies here.
Finally all CNS funneled out!
Go time is near
funnel out the CNS's
Yes Sir! I's waiting!
I find it funny that last 6 months of this has literally been all buyers. Once they funnel out the junk, we should see a huge pop
No shares below.
This is really good
Are they stop loss hunting today?
Do people not realize there are tons in insider $0.60 warrants?
That minimum share price is $1.00 for Nasdaq small cap?
This is going over a dollar sooner than later. After that their trial results will determine how high we fly.
Phase 2 is the time to invest in biotech!!
Followers
|
179
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
5870
|
Created
|
10/10/08
|
Type
|
Free
|
Moderators |
Contacts:
For EOM Pharmaceuticals, Inc:
INVESTOR CONTACT: Wayne I. Danson
Chief Financial Officer & Treasurer
EOM Pharmaceuticals, Inc.
wayned@eompharma.com
516.384.9757
MEDIA CONTACT: Taylor Mason-Little
TogoRun
t.mason-little@togorun.com
714.466.0301
For ImmunoCellular Therapeutics, Inc:
Jane M. Green
jane@jmgcomm.com
267.457.3734 office
415.652.4819 mobile
SOURCE EOM Pharmaceuticals, Inc.
IMUC SHARE STRUCTURE